Chest and back pain associated with a six-hour infusion of Liposomal daunorubicin

被引:3
作者
Hui, YF
Cortes, JE
机构
[1] Univ Texas, MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
D O I
10.1345/aph.19236
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:810 / 811
页数:2
相关论文
共 13 条
[1]   Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients [J].
Andstrom, EE ;
Ringden, O ;
Remberger, M ;
Svahn, BM ;
Tollemar, J .
MYCOSES, 1996, 39 (5-6) :185-193
[2]   Phase I study of liposomal daunorubicin in patients with acute leukemia [J].
Cortes, J ;
O'Brien, S ;
Estey, E ;
Giles, F ;
Keating, M ;
Kantarjian, H .
INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) :81-87
[3]  
Cortes J, 1998, BLOOD, V92, p234A
[4]   A PHASE-II TRIAL OF DAUNOXOME, LIPOSOME-ENCAPSULATED DAUNORUBICIN, IN PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE COLON [J].
ECKARDT, JR ;
CAMPBELL, E ;
BURRIS, HA ;
WEISS, GR ;
RODRIGUEZ, GI ;
FIELDS, SM ;
THURMAN, AM ;
PEACOCK, NW ;
COBB, P ;
ROTHENBERG, ML ;
ROSS, ME ;
VONHOFF, DD .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (06) :498-501
[5]   A phase II study of DaunoXome® in advanced urothelial transitional cell carcinoma [J].
Fosså, SD ;
Aass, N ;
Parö, G .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (07) :1131-1132
[6]   CARDIOPULMONARY TOXICITY AFTER LIPOSOMAL AMPHOTERICIN-B INFUSION [J].
LEVINE, SJ ;
WALSH, TJ ;
MARTINEZ, A ;
EICHACKER, PQ ;
LOPEZBERESTEIN, G ;
NATANSON, C .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (08) :664-666
[7]   PULMONARY INTRAVASCULAR MACROPHAGES AND HEMODYNAMIC-EFFECTS OF LIPOSOMES IN SHEEP [J].
MIYAMOTO, K ;
SCHULTZ, E ;
HEATH, T ;
MITCHELL, MD ;
ALBERTINE, KH ;
STAUB, NC .
JOURNAL OF APPLIED PHYSIOLOGY, 1988, 64 (03) :1143-1152
[8]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[9]  
*NEXST PHARM, 1996, INV BROCH DAUN
[10]   Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial [J].
Northfelt, DW ;
Dezube, BJ ;
Thommes, JA ;
Miller, BJ ;
Fischl, MA ;
Friedman-Kien, A ;
Kaplan, LD ;
Du Mond, C ;
Mamelok, RD ;
Henry, DH .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2445-2451